You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

Returns | 1W : 2.7% , 1M : -8.8%,1Y : 37.2%
BOM : 532296     NSE : GLENMARK    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Aug 03,2021
Price(EOD): Rs. 604.20
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
GLENMARK PHARMACEUTICALS 2.7% -8.8% 37.2%
SUN PHARMACEUTICAL INDUSTRIES 15.6% 16.8% 51.9%
DR REDDYS LABORATORIES -0.2% -15.3% 4.1%
DIVIS LABORATORIES 2.4% 10.8% 92.4%
CIPLA 4.2% -5.3% 34.4%
BIOCON 2.1% -4.4% -3.3%
AUROBINDO PHARMA 0.2% -7.7% 11.9%
LUPIN 3.6% -1.4% 26.3%
TORRENT PHARMACEUTICALS 0.6% 5.2% 26.2%


FUNDAMENTAL ANALYSIS OF GLENMARK PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Mar2021, Y: Mar2020
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]
Show Me the Stocks with Fundamentals better than GLENMARK PHARMACEUTICALS Plus/Pro


VALUATION OF GLENMARK PHARMACEUTICALS

 
Valuation Score
[As on : Aug 03,2021 ]

Ratio Consolidated
P/E
P/B
P/S
21.97
P/E Calculated based on EPS of 27.5
[ Mar2020 - Consolidated Results ]

2.81
P/B Calculated based on Book Value of 214.65
[ Mar2020 - Consolidated Results ]

1.56
P/S Calculated based on Revenues of 10943.9 Cr
[ TTM - Consolidated Results ]

Show Me the Stocks with Valuation better than GLENMARK PHARMACEUTICALS Plus/Pro


FAIR VALUE OF GLENMARK PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-19%
-47%
-41%

SHARE PRICE MOMENTUM OF GLENMARK PHARMACEUTICALS

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.27
0.26
0.29
0.27
0.8
0.8
0.9
0.83
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Jun2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
2.62%
-1.25%
-3.01%
-5.77%
3.34%
12.4%
6.15%
6.16%
QtrlyTrend
2
Latest Qtr: Mar2021

GLENMARK PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 3.6% 2% 48.8%
S&P BSE 150 MIDCAP 3.5% 4.7% 84.4%
S&P BSE 400 MIDSMALLCAP 2.9% 5.3% 92.3%
S&P BSE 250 LARGEMIDCAP 2.7% 3% 49.8%
S&P BSE ALLCAP 2.7% 3.4% 54.8%
S&P BSE 200 2.7% 3% 49.1%
S&P BSE 500 2.7% 3.2% 53%
S&P BSE LARGE MIDCAP 2.6% 2.9% 47.6%
S&P BSE MIDSMALLCAP 2.6% 5.1% 90.2%
S&P BSE MID CAP 2.2% 3.9% 70.2%
S&P BSE MOMENTUM 1.8% 2% 34.9%
NSE Indices1W1M1Y
NIFTY MIDCAP 50 4.1% 4.6% 82.7%
NIFTY FREE MIDCAP 100 3.5% 4.6% 83.4%
NIFTY MIDCAP150 3.2% 4.3% 82.4%
NIFTY MID SMALL400 2.8% 5.2% 91.7%
NIFTY 200 2.7% 3% 48.2%
NIFTY 500 2.7% 3.3% 52.6%
NIFTY HEALTHCARE 2.5% 1.4% NA
NIFTY LARGE MIDCAP 250 1.8% 3.1% 59.4%
NIFTY500 MULTICAP 50:25:25 1.6% 4% NA

FAQ [Frequently Asked Questions]


Is GLENMARK PHARMACEUTICALS good for long term investment?

As on 03-Aug-2021, the Fundamentals of GLENMARK PHARMACEUTICALS look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of GLENMARK PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is GLENMARK PHARMACEUTICALS UnderValued or OverValued?

As on 03-Aug-2021, GLENMARK PHARMACEUTICALS is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of GLENMARK PHARMACEUTICALS ?

As on 03-Aug-2021, the Intrinsic Value of GLENMARK PHARMACEUTICALS is Rs. 1,025.75 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 745.99
Fair Value [Median EV / Sales Model] : Rs. 1,131.20
Fair Value [Median Price / Sales Model] : Rs. 1,025.75
Median Fair Value of GLENMARK PHARMACEUTICALS : Rs. 1,025.75

Is GLENMARK PHARMACEUTICALS trading at a Premium or Discount?

As on 03-Aug-2021, GLENMARK PHARMACEUTICALS is trading at a Discount of -41% based on the estimates of Median Intrinsic Value!

What is the Financial Performance of Industry Peers of GLENMARK PHARMACEUTICALS ?

Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of BIOCON LTD | BOM: 532523 | NSE: BIOCON
Share Price & Financials of AUROBINDO PHARMA LTD | BOM: 524804 | NSE: AUROPHARMA
Share Price & Financials of LUPIN LTD | BOM: 500257 | NSE: LUPIN
Share Price & Financials of TORRENT PHARMACEUTICALS LTD | BOM: 500420 | NSE: TORNTPHARM
Share Price & Financials of CADILA HEALTHCARE LTD | BOM: 532321 | NSE: CADILAHC
Share Price & Financials of ABBOTT INDIA LTD | BOM: 500488 | NSE: ABBOTINDIA
Check out Quarterly Results of Industry Peers
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of BIOCON LTD
Quarterly Results of AUROBINDO PHARMA LTD
Quarterly Results of LUPIN LTD
Quarterly Results of TORRENT PHARMACEUTICALS LTD
Quarterly Results of CADILA HEALTHCARE LTD
Quarterly Results of ABBOTT INDIA LTD

What are the Frequent Comparisons with GLENMARK PHARMACEUTICALS ?

Compare Analytics
GLENMARK PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
GLENMARK PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
GLENMARK PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
GLENMARK PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
GLENMARK PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
GLENMARK PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
GLENMARK PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
GLENMARK PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
GLENMARK PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of BIOCON LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of LUPIN LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of ABBOTT INDIA LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z